Skip to main content
Van Huynh, MD, Pediatric Hematology & Oncology, Orange, CA, Children’s Health Orange County (CHOC)

VanThuHuynhMD

Pediatric Hematology & Oncology Orange, CA

Pediatric Hematologic Oncology

Assistant Division Chief of Oncology, CHOC Children's Hospital; Director, Leukemia Program, Section Director, CAR T Cell Program Associate Clinical Professor, Pediatrics, UC Irvine

Dr. Huynh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huynh's full profile

Already have an account?

Summary

  • Dr. Van Huynh is a pediatric hematologist/oncologist in Orange, CA and is affiliated with Children's Hospital of Orange County. She received her medical degree from University of California Irvine School of Medicine and has been in practice 9 years. She also speaks multiple languages, including Vietnamese. She specializes in pediatric oncology.

Education & Training

  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 2004 - 2007
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology
  • Hematology/OncologyHematology/Oncology

Awards, Honors, & Recognition

  • PSF Tithe Award "A pilot Study of asparaginase level drug monitoring in pediatric leukemia patients, 2016

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML:...
    Van Thu Huynh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Other Languages

  • Vietnamese

Hospital Affiliations